Viewing StudyNCT00005598



Ignite Creation Date: 2024-05-05 @ 10:00 AM
Last Modification Date: 2024-10-26 @ 9:05 AM
Study NCT ID: NCT00005598
Status: COMPLETED
Last Update Posted: 2012-12-21
First Post: 2000-05-02

Brief Title: Azacitidine Plus Amifostine in Treating Patients With Myelodysplastic Syndrome
Sponsor:
Organization: University of Michigan Rogel Cancer Center

Study Design

Study Type: INTERVENTIONAL
Expanded Access Type Individual: None
Expanded Access Type Intermediate: None
Expanded Access Type Treatment: None
Patient Registry: None
Target Duration: None
Design Allocation:
Design Intervention Model:
Design Intervention Model Description:
Design Masking Description:
Bio Spec Retention: None
Bio Spec Description: None
Enrollment Count: None
Enrollment Type: None
Design Primary Purpose:
Design Masking:
Phases:
Name
PHASE2
Observational Models:
Time Perspective List:
Who Masked List: